Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

Fabiola Carrara; Piero Ruggenenti; Annalisa Perna; Ilian Iliev; Flavio Gaspari; Silvia Ferrari; Nadia Stucchi; Antonio Bossi; Roberto Trevisan; Giuseppe Remuzzi; Aneliya Parvanova

doi:10.1007/s00592-021-01804-9

Shared by

Giuseppe Remuzzi

Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

Article 2021 en

Authors

FC
Fabiola Carrara
PR
Piero Ruggenenti
AP
Annalisa Perna

Related publications

Article2017

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Misghina Weldegiorgis, Dick de Zeeuw, Liang Li, Hans‐Henrik Parving, Fan Fan Hou, Giuseppe Remuzzi, Tom Greene, Hiddo J.L. Heerspink

Article2003

Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy

Piero Ruggenenti, Claudio Flores, C. Aros, Bogdan Ene‐Iordache, Roberto Trevisan, Cosimo Ottomano, Giuseppe Remuzzi

Chapter in a book2004

NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS, PREDICTORS OF OUTCOME

Gozewijn D. Laverman, Piero Ruggenenti, Giuseppe Remuzzi

Chapter in a book2010

NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS, PREDICTORS OF OUTCOME

Gozewijn D. Laverman, Piero Ruggenenti, Giuseppe Remuzzi

Article2013

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

Flavio Gaspari, Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Antonio Cannatà, Fabiola Carrara, Alejandro Jiménez, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Aneliya Parvanova, Ilian Iliev, Roberto Trevisan, Antonio Bossi, Jelka Zaletel, Giuseppe Remuzzi

Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

Discussion(0)

Related publications

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy

NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS, PREDICTORS OF OUTCOME

NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS, PREDICTORS OF OUTCOME

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics